191 related articles for article (PubMed ID: 20855747)
1. Differential Aspergillus lentulus echinocandin susceptibilities are Fksp independent.
Staab JF; Kahn JN; Marr KA
Antimicrob Agents Chemother; 2010 Dec; 54(12):4992-8. PubMed ID: 20855747
[TBL] [Abstract][Full Text] [Related]
2. Stress-Induced Changes in the Lipid Microenvironment of β-(1,3)-d-Glucan Synthase Cause Clinically Important Echinocandin Resistance in Aspergillus fumigatus.
Satish S; Jiménez-Ortigosa C; Zhao Y; Lee MH; Dolgov E; Krüger T; Park S; Denning DW; Kniemeyer O; Brakhage AA; Perlin DS
mBio; 2019 Jun; 10(3):. PubMed ID: 31164462
[No Abstract] [Full Text] [Related]
3. The Paradoxical Effect of Echinocandins in Aspergillus fumigatus Relies on Recovery of the β-1,3-Glucan Synthase Fks1.
Loiko V; Wagener J
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872079
[TBL] [Abstract][Full Text] [Related]
4. Current perspectives on echinocandin class drugs.
Perlin DS
Future Microbiol; 2011 Apr; 6(4):441-57. PubMed ID: 21526945
[TBL] [Abstract][Full Text] [Related]
5. Target enzyme mutations confer differential echinocandin susceptibilities in Candida kefyr.
Staab JF; Neofytos D; Rhee P; Jiménez-Ortigosa C; Zhang SX; Perlin DS; Marr KA
Antimicrob Agents Chemother; 2014 Sep; 58(9):5421-7. PubMed ID: 24982083
[TBL] [Abstract][Full Text] [Related]
6. [In vitro activity of anidulafungin. Comparison with the activity of other echinocandins].
Martín Mazuelos E; Rodríguez-Tudela JL
Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():7-13. PubMed ID: 19572429
[TBL] [Abstract][Full Text] [Related]
7. Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint.
Garcia-Effron G; Lee S; Park S; Cleary JD; Perlin DS
Antimicrob Agents Chemother; 2009 Sep; 53(9):3690-9. PubMed ID: 19546367
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous Mutational Frequency and
Shields RK; Kline EG; Healey KR; Kordalewska M; Perlin DS; Nguyen MH; Clancy CJ
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373796
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of chitin synthases by calcineurin controls paradoxical growth of Aspergillus fumigatus in response to caspofungin.
Fortwendel JR; Juvvadi PR; Perfect BZ; Rogg LE; Perfect JR; Steinbach WJ
Antimicrob Agents Chemother; 2010 Apr; 54(4):1555-63. PubMed ID: 20124000
[TBL] [Abstract][Full Text] [Related]
10. FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance.
Zimbeck AJ; Iqbal N; Ahlquist AM; Farley MM; Harrison LH; Chiller T; Lockhart SR
Antimicrob Agents Chemother; 2010 Dec; 54(12):5042-7. PubMed ID: 20837754
[TBL] [Abstract][Full Text] [Related]
11. Role of FKS Gene in the Susceptibility of Pathogenic Fungi to Echinocandins.
Hori Y; Shibuya K
Med Mycol J; 2018; 59(2):E31-E40. PubMed ID: 29848909
[TBL] [Abstract][Full Text] [Related]
12. Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment.
Lackner M; Tscherner M; Schaller M; Kuchler K; Mair C; Sartori B; Istel F; Arendrup MC; Lass-Flörl C
Antimicrob Agents Chemother; 2014 Jul; 58(7):3626-35. PubMed ID: 24733467
[TBL] [Abstract][Full Text] [Related]
13. Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity.
Niimi K; Monk BC; Hirai A; Hatakenaka K; Umeyama T; Lamping E; Maki K; Tanabe K; Kamimura T; Ikeda F; Uehara Y; Kano R; Hasegawa A; Cannon RD; Niimi M
J Antimicrob Chemother; 2010 May; 65(5):842-52. PubMed ID: 20233776
[TBL] [Abstract][Full Text] [Related]
14. Caspofungin Treatment of Aspergillus fumigatus Results in ChsG-Dependent Upregulation of Chitin Synthesis and the Formation of Chitin-Rich Microcolonies.
Walker LA; Lee KK; Munro CA; Gow NA
Antimicrob Agents Chemother; 2015 Oct; 59(10):5932-41. PubMed ID: 26169407
[TBL] [Abstract][Full Text] [Related]
15. Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit.
Ghannoum MA; Chen A; Buhari M; Chandra J; Mukherjee PK; Baxa D; Golembieski A; Vazquez JA
Clin Microbiol Infect; 2009 Mar; 15(3):274-9. PubMed ID: 19210699
[TBL] [Abstract][Full Text] [Related]
16. Echinocandin antifungal drugs in fungal infections: a comparison.
Chen SC; Slavin MA; Sorrell TC
Drugs; 2011 Jan; 71(1):11-41. PubMed ID: 21175238
[TBL] [Abstract][Full Text] [Related]
17. Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates.
Pfaller MA; Messer SA; Rhomberg PR; Jones RN; Castanheira M
J Antimicrob Chemother; 2016 Oct; 71(10):2868-73. PubMed ID: 27287236
[TBL] [Abstract][Full Text] [Related]
18. Sequencing of
Arrieta-Aguirre I; Menéndez-Manjón P; Cuétara MS; Fernández de Larrinoa I; García-Ruiz JC; Moragues MD
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29229638
[No Abstract] [Full Text] [Related]
19. Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints.
Garcia-Effron G; Park S; Perlin DS
Antimicrob Agents Chemother; 2009 Jan; 53(1):112-22. PubMed ID: 18955538
[TBL] [Abstract][Full Text] [Related]
20. The
Ries LNA; Rocha MC; de Castro PA; Silva-Rocha R; Silva RN; Freitas FZ; de Assis LJ; Bertolini MC; Malavazi I; Goldman GH
mBio; 2017 Jun; 8(3):. PubMed ID: 28611248
[No Abstract] [Full Text] [Related]
[Next] [New Search]